![](\"https:\/\/tctechcrunch2011.files.wordpress.com\/2010\/11\/cash-pile.jpg?w=362\")
<\/p>\n<\/p>\n
At three years old, Oak HC\/FT<\/a> is a young firm. But its investors clearly have faith in the outfit. It closed its debut fund with $500 million in late 2014; yesterday, it closed its second fund with $600 million.<\/p>\n Having a parent company that\u00a0investors know well goes a long way in explaining their trust. Oak HC\/FT spun out of\u00a0Oak Investment Partners<\/a>, a powerhouse that\u00a0manages more than a dozen funds focused on private equity-type investments in tech and has invested billions of dollars in hundreds of companies since its 1978 founding.<\/p>\n The younger carve-out\u00a0\u2014 which is\u00a0focus exclusively on financial and health care technology\u00a0companies\u00a0\u2014 also has its share of star power, including\u00a0Annie Lamont, who joined Oak in 1982\u00a0and is the managing partner of Oak HC\/FT; her\u00a0many bets over the years include Castlight Health<\/a>, a\u00a0health benefits platform that went public in 2014, and Poynt<\/a>, a three-year-old, software-enabled point-of-sale device that merchants use to accept credit and debit cards.<\/p>\n The firm, which features seven full-time investors (plus two analysts), also counts among its four venture partners\u00a0Zeke Emanuel, the famous oncologist and bioethicist.<\/p>\n Oak HC\/FT typically looks to invest between $5 million and $50 million in growth-stage companies, and between $15 million and $35 million in earlier-stage venture startups. Some of its largest bets to date include LDI<\/a>, a\u00a0full-service pharmacy benefit management company;\u00a0VillageMD<\/a>, management services company that partners with healthcare providers to improve care delivery; and, on the fintech side, Insureon<\/a>, an online agency that provides insurance protection services for small businesses.<\/p>\n Worth noting: the firm does not define healthcare as encompassing\u00a0bioengineering startups or medical devices but rather pharmaceutical services,\u00a0alternative care delivery models, and sub-population management companies.<\/p>\n Others of its investment include Aspire Health<\/a>, a Nashville-based provider of home and outpatient-based palliative care;\u00a0Feedzai<\/a>, a San Mateo, Ca.-based startup\u00a0that\u00a0uses machine-learning to reduce financial fraud; and Trov<\/a>, a next-generation insurance platform in Danville, Ca., that sells\u00a0on-demand micro insurance for products.<\/p>\n Last month, the firm saw its first exit, too: Thermo Fisher Scientific\u2019s acquisition<\/a> of Core Informatics, a cloud-based platform supporting scientific data management. Terms of the deal were not disclosed. According to Crunchbase, the 11-year-old company had raised $22.5 million<\/a> from investors, including $17.5 million in Series B funding from Oak HC\/FT in 2015.<\/p>\n","protected":false},"excerpt":{"rendered":" At three years old, Oak HC\/FT is a young firm. But its investors clearly have faith in the outfit. It closed its debut fund with $500 million in late 2014; yesterday, it closed its second fund with $600 million. Having a parent company that\u00a0investors know well goes a long way in explaining their trust. Oak HC\/FT spun out of\u00a0Oak Investment Partners, a powerhouse that\u00a0manages more than a… Read More<\/a><\/p>\n\n<\/img><\/a>
<\/img><\/a>
<\/img><\/a>
<\/img><\/a>
<\/img><\/a>
<\/img><\/a>\n<\/div>\n
<\/p>\n","protected":false},"author":5817,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[25],"tags":[59,66,26],"class_list":["post-338660","post","type-post","status-publish","format-standard","hentry","category-technology","tag-media","tag-techcrunch","tag-technology"],"_links":{"self":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/posts\/338660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/users\/5817"}],"replies":[{"embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/comments?post=338660"}],"version-history":[{"count":0,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/posts\/338660\/revisions"}],"wp:attachment":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/media?parent=338660"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/categories?post=338660"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/tags?post=338660"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}